Joyce Kenneth M, McInerney Niall M, Waters Peadar S, Sweeney Karl J, Barry Kevin, Kerin Michael J
Discipline of Surgery, National Breast Cancer Research Institute, Galway University Hospital, Galway, Ireland.
Discipline of Surgery, National Breast Cancer Research Institute, Galway University Hospital, Galway, Ireland.
Clin Breast Cancer. 2015 Apr;15(2):e125-30. doi: 10.1016/j.clbc.2014.11.001. Epub 2014 Nov 10.
Consensus exists that screening mammography is appropriate for women aged 50 to 69 years. However, the effectiveness of such screening for women aged 40 to 50 years is still questioned. The aim of our study was to analyze breast cancer management in the 40- to 50-year age group. We also wished to determine the proportion of patients with a significant family history and whether this was associated with more advanced disease.
All female patients with primary breast cancer diagnosed between 40 and 50 years of age were included over a 4-year period. The database of the National Breast Cancer Research Institute was interrogated, and a chart and radiology review carried out to obtain relevant details of clinical presentation, family history, radiological findings, and treatments undertaken.
Three hundred thirty-four patients were diagnosed in this cohort during the study period. Twenty-two percent of those diagnosed had a family history of breast cancer with 1.8% having a genetically confirmed predisposition to breast cancer. A significant proportion of patients presented with advanced disease, with 50% of patients having nodal involvement and 3% who presented with distant metastases. The overall rate of mastectomy was 47%, with minimal variation between the surgeons who performed the surgeries. More than half of the patients in our analysis underwent axillary clearance (51%).
Our results indicate that a large proportion of patients in the 40- to 50-year age group presented with advanced disease and required aggressive surgical and adjuvant treatment. The presence of a family history did not identify a subgroup with more advanced disease at presentation.
目前已达成共识,乳腺钼靶筛查适用于50至69岁的女性。然而,这种筛查对40至50岁女性的有效性仍受到质疑。我们研究的目的是分析40至50岁年龄组的乳腺癌管理情况。我们还希望确定有显著家族病史的患者比例,以及这是否与更晚期的疾病相关。
纳入4年内确诊的所有40至50岁原发性乳腺癌女性患者。查询了国家乳腺癌研究所的数据库,并进行了病历和影像学审查,以获取临床表现、家族病史、影像学检查结果及所采取治疗措施的相关详细信息。
在研究期间,该队列中有334例患者被确诊。其中22%的确诊患者有乳腺癌家族史,1.8%的患者有经基因确认的乳腺癌易感性。相当一部分患者表现为晚期疾病,50%的患者有淋巴结受累,3%的患者有远处转移。乳房切除术的总体比例为47%,实施手术的外科医生之间差异极小。我们分析中超过一半的患者接受了腋窝清扫术(51%)。
我们的结果表明,40至50岁年龄组中的很大一部分患者表现为晚期疾病,需要积极的手术和辅助治疗。家族病史的存在并未识别出就诊时疾病更晚期的亚组。